Neumora
PublicLast Round
IPO Announced
Sep 15, 2023
Est. Valuation
$2.58B
Total Funding Raised
$862.1M
Company Overview
Neumora is a biopharmaceutical company focused on developing innovative treatments for neuropsychiatric disorders and neurodegenerative diseases through a unique approach to neuroscience.
Sector
Biotech
AI Layer
Infrastructure
Keywords
precision medicines for brain diseasesdata-driven precision neuroscience platformsmall-molecule drug development for neuroscienceData Biopsy Signatures for patient subtypingtherapeutics for Major Depressive Disorder (MDD)therapeutics for Schizophreniatherapeutics for neurodegenerative disordersdata science platform for drug discoverykappa opioid receptor antagonisttherapeutics for agitation in Alzheimer's diseaseM4 positive allosteric modulatorbiotech R&D collaboration modelNLRP3 inhibitor for obesity
Neumora Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Neumora Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Sep 15, 2023 | ||||
| Series B | Oct 11, 2022 | ||||
| Series A | Oct 7, 2021 |
Neumora Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newpath Partners | Series B, Series A |
| Surveyor Capital | Series A |
| SoftBank Investment Advisers | Series A |
| DisruptAD | Series B |
| Guggenheim Securities | IPO |
| Waycross Ventures | Series A |
| Altitude Life Science Ventures | Series A, Series B |
Neumora Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersWatertown, Massachusetts
Employee Range109
Year Founded2020
Last FundingSep 15, 2023